1. Home
  2. STN vs JAZZ Comparison

STN vs JAZZ Comparison

Compare STN & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stantec Inc

STN

Stantec Inc

HOLD

Current Price

$101.69

Market Cap

11.3B

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$170.94

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STN
JAZZ
Founded
1954
2003
Country
Canada
Ireland
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3B
10.4B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
STN
JAZZ
Price
$101.69
$170.94
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
$207.19
AVG Volume (30 Days)
293.2K
1.1M
Earning Date
02-25-2026
02-24-2026
Dividend Yield
0.65%
N/A
EPS Growth
44.12
N/A
EPS
3.04
N/A
Revenue
$4,547,020,941.00
$4,157,832,999.00
Revenue This Year
$12.14
$6.00
Revenue Next Year
$10.00
$6.35
P/E Ratio
$32.52
N/A
Revenue Growth
12.49
4.14
52 Week Low
$73.18
$95.49
52 Week High
$114.52
$182.99

Technical Indicators

Market Signals
Indicator
STN
JAZZ
Relative Strength Index (RSI) 63.37 55.75
Support Level $97.42 $165.01
Resistance Level $100.65 $172.59
Average True Range (ATR) 2.00 6.13
MACD 0.46 0.01
Stochastic Oscillator 93.16 74.54

Price Performance

Historical Comparison
STN
JAZZ

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: